Abstract
Clinically unsuspected pituitary adenomas are common among adults on autopsy and MRI survey. Acute pituitary hemorrhage is far more rare. We report a case of a 61-year-old male patient with locally advanced prostate cancer who presented with an acute picture of pituitary apoplexy after his first dose of leuprolide. He developed headache and neck pain within a few hours of treatment followed by nausea, vomiting, ptosis and diplopia. Pituitary apoplexy is a potentially life threatening medical emergency. Although the pathophysiology is poorly defined, various conditions and treatments have been reported to trigger apoplexy. Apoplexy has been reported in response to pituitary stimulation by GnRH or GnRH-agonists. Initial stimulatory effects of gonadotropin releasing hormone (GnRH) analogue may induce apoplexy in patients with asymptomatic gonadotroph adenomas.
Similar content being viewed by others
References
Teramoto A, Hirawaka K, Sanno N, Osamura Y (1994) Incidental pituitary lesions in 1000 unselected autopsy specimens. Radiology 93:16–24
Chong BW, Kucharczyk W, Singer W, George S (1994) Pituitary gland MR: A comparative study of healthy volunteers and patients with microadenomas. Am J Neuroradiol 15:675–679
Cardoso ER, Peterson EW (1984) Pituitary apoplexy: A review. Neurosurgery 14:363–373
Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JAH (1999) Classical pituitary apoplexy: Clinical features, management and outcome. Clin Endocrinol 51:181–188
Biousse V, Newman NJ, Oyesiku NM (2001) Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 71:542–545
Conn PM, Crowley WF (1991) Gonadotropin-releasing hormone and its analogues. N England J Med 324:93–103
Ando S, Hoshino T, Mihara S (1995) Pituitary apoplexy after goserelin. Lancet 345:458
Eaton HJ, Phillips PJ, Hanieh A, Cooper J, Bolt J, Torpy DJ (2001) Rapid onset of pituitary apoplexy after goserelin implant for prostate cancer: Need for heightened awareness. Intern Med J 31:313–314
Thompson IM, Zeidman EJ, Rodriguez FR (2001) Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate. J Urol 144:1479–1480
Chanson P, Schaison G (1995) Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma. J Clin Endocrinol Metab 80:2267–2268
Reznick Y, Chapon F, Lahlou N, Deboucher N, Mahoudeau J (1997) Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer. J Endocrinol Invest 20:566–568
Morsi A, Jamal S, Silverberg JDH (1996) Pituitary apoplexy after leuprolide administration for carcinoma of the prostate. Clin Endocrinol 44:121–124
Korsic M, Lelas-Bahun N, Surdoja P, Besenski N, Horvat S, Plavsic V (1984) Infarction of FSH-secreting pituitary adenoma. Acta Endocrinol (Copenh) 107:149–154
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Davis, A., Goel, S., Picolos, M. et al. Pituitary apoplexy after leuprolide. Pituitary 9, 263–265 (2006). https://doi.org/10.1007/s11102-006-8616-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-006-8616-6